Marshall Wace North America’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-13,298
Closed -$1.73M – 1669
2021
Q1
$1.73M Buy
13,298
+5,721
+76% +$734K 0.01% 873
2020
Q4
$910K Sell
7,577
-12,429
-62% -$1.22M ﹤0.01% 964
2020
Q3
$1.49M Buy
+20,006
New +$1.39M 0.01% 679
2020
Q2
– Sell
-19,244
Closed -$1.26M – 1379
2020
Q1
$1.26M Sell
19,244
-10,486
-35% -$835K 0.01% 570
2019
Q4
$2.43M Buy
29,730
+28,847
+3,267% +$2.21M 0.01% 537
2019
Q3
$64K Buy
+883
New +$64.8K ﹤0.01% 1125
2019
Q1
– Sell
-2,113
Closed -$129K – 1802
2018
Q4
$129K Buy
+2,113
New +$143K ﹤0.01% 1039
2018
Q2
– Sell
-40,674
Closed -$1.76M – 1603
2018
Q1
$1.76M Buy
+40,674
New +$1.87M 0.01% 842

Other funds holding OMCL

Marshall Wace North America's OMCL Position: Q2 2021 in Review

Marshall Wace North America sold out of Omnicell (OMCL) in Q2 2021, closing a stake of 13,298 shares — an estimated $1.73M sold.

Marshall Wace North America first reported a position in OMCL in Q1 2018 and held it in 8 quarters. The position peaked at $2.43M in Q4 2019. 377 funds tracked by Wall St. Rank hold OMCL as of Q2 2021.

  • Marshall Wace North America reported no remaining Omnicell position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 13,298 Omnicell shares in Q2 2021, an estimated $1.73M.
  • Marshall Wace North America first reported a position in Omnicell in Q1 2018 and held it in 8 quarters.
  • Marshall Wace North America's Omnicell position peaked at $2.43M in Q4 2019.
  • 377 funds tracked by Wall St. Rank held Omnicell as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.